| __timestamp | AstraZeneca PLC | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 1488000000 |
| Thursday, January 1, 2015 | 5997000000 | 1525000000 |
| Friday, January 1, 2016 | 5890000000 | 2111000000 |
| Sunday, January 1, 2017 | 5757000000 | 1848000000 |
| Monday, January 1, 2018 | 5932000000 | 1213000000 |
| Tuesday, January 1, 2019 | 5958000000 | 1010000000 |
| Wednesday, January 1, 2020 | 5991000000 | 997000000 |
| Friday, January 1, 2021 | 9736000000 | 967000000 |
| Saturday, January 1, 2022 | 9762000000 | 838000000 |
| Sunday, January 1, 2023 | 10935000000 | 953000000 |
| Monday, January 1, 2024 | 13583000000 | 998000000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, AstraZeneca PLC has consistently outpaced Teva Pharmaceutical Industries Limited in R&D investment. From 2014 to 2023, AstraZeneca's R&D expenses surged by nearly 96%, peaking in 2023 with an investment of over $10 billion. In contrast, Teva's R&D spending saw a decline of approximately 36% during the same period, reflecting strategic shifts and market challenges.
AstraZeneca's commitment to R&D is evident in its steady increase in investment, particularly from 2020 onwards, where it saw a significant jump of over 60% in just three years. This strategic focus has positioned AstraZeneca as a leader in pharmaceutical innovation.
Teva, on the other hand, faced a downward trend, with R&D expenses dropping to under $1 billion by 2023, highlighting the company's need to reassess its innovation strategies.
Novo Nordisk A/S or Teva Pharmaceutical Industries Limited: Who Invests More in Innovation?
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc. Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs MannKind Corporation: Strategic Focus on R&D Spending